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The p53 tumor suppressor acts as a guardian of the genome by
preventing the propagation of DNA damage-induced breaks and
mutations to subsequent generations of cells. We have previously
shown that phosphorylation of the Mdm2 oncoprotein at Ser394 by
the ATM kinase is required for robust p53 stabilization and activation
in cells treated with ionizing radiation, and that loss of Mdm2 Ser394
phosphorylation leads to spontaneous tumorigenesis and radioresist-
ance inMdm2S394Amice. Previous in vitro data indicate that the c-Abl
kinase phosphorylates Mdm2 at the neighboring residue (Tyr393) in
response to DNA damage to regulate p53-dependent apoptosis. In
this present study, we have generated an Mdm2 mutant mouse
(Mdm2Y393F) to determine whether c-Abl phosphorylation of Mdm2
regulates the p53-mediated DNA damage response or p53 tumor
suppression in vivo. The Mdm2Y393F mice develop accelerated spon-
taneous and oncogene-induced tumors, yet display no defects in p53
stabilization and activity following acute genotoxic stress. Although
apoptosis is unaltered in these mice, they recover more rapidly from
radiation-induced bone marrow ablation and are more resistant to
whole-body radiation-induced lethality. These data reveal an in vivo
role for c-Abl phosphorylation of Mdm2 in regulation of p53 tumor
suppression and bone marrow failure. However, c-Abl phosphor-
ylation of Mdm2 Tyr393 appears to play a lesser role in governing
Mdm2-p53 signaling than ATM phosphorylation of Mdm2 Ser394.
Furthermore, the effects of these phosphorylation events on p53
regulation are not additive, as Mdm2Y393F/S394A mice and
Mdm2S394A mice display similar phenotypes.
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The significant role of p53 in human tumor suppression isevidenced by the fact that p53 is either mutated or func-
tionally inactive in over 50% of human cancers (1). The tumor
suppressive activity of p53 has been classically attributed to p53-
dependent cellular responses of growth arrest and apoptosis in
response to various stresses, although increasing evidence has
implicated additional p53-target genes involved in regulating
further cellular processes such as metabolic functions and DNA
repair (2, 3). Stress-induced p53 responses are preceded by a
profound increase in p53 protein levels and transcriptional activity.
Accordingly, understanding the signaling events that lead to p53
stabilization and transcriptional activation has been the focus of
extensive research. In order for p53 levels and activity to increase in
the damaged cell, p53 must be relieved of the negative regulation
imposed by the MDM oncoproteins, Mdm2 and MdmX.
Regulation of the DNA damage response (DDR) in mammals is
governed by the PI3K-related ATM and ATR kinases. Activation of
these transducer kinases depends on the type and amount of DNA
damage and triggers the direct or indirect phosphorylation of nu-
merous downstream proteins involved in the DDR (4, 5). ATM is
activated primarily by double-strand breaks (DSBs), and its nu-
merous target substrates include p53, Mdm2, and MdmX (6–10).
We have previously reported the generation of a mouse model
(Mdm2S394A) in which ATM phosphorylation of Mdm2 at serine
residue 394 (Ser395 in human MDM2) was abolished (11). Cells
and tissues of Mdm2S394A mice display profound defects in DNA
damage-induced p53 protein stabilization and transcriptional ac-
tivation. The diminished p53 response in these animals resulted in
reduced p53-dependent apoptosis in hematopoietic tissues,
radioresistance, and increased spontaneous tumorigenesis.
These findings underscore that Mdm2 phosphorylation is a
critical event in regulating Mdm2-p53 signaling and the induction
of p53 activity during the DDR and in homeostatic tissues. However,
Mdm2S394A mice display some p53 stabilization and activity following
DNA damage and do not fully phenocopy p53−/−mice. This led us to
examine whether the phosphorylation of additional Mdm2 residues
contributes to p53 induction following DNA damage.
Intriguingly, the tyrosine residue immediately preceding Ser395
in human MDM2, Tyr394 (Tyr393 in mouse Mdm2), has been
shown to be phosphorylated by the tyrosine kinase c-Abl (12, 13).
Similar to ATM and ATR, c-Abl is activated by a variety of DNA
damaging agents (14–16). Previous overexpression studies in cell
lines indicate that c-Abl promotes growth arrest in a p53-dependent
manner and apoptosis by both p53-dependent and independent
mechanisms (17, 18). Furthermore, c-Abl can protect p53 from
MDM2-mediated degradation, and c-Abl phosphorylation of
MDM2 overcomes the inhibitory effect of MDM2 on p53 tran-
scriptional activity and apoptosis (19). In addition, studies using
c-abl−/− mouse embryonic fibroblasts (MEFs) indicate that c-Abl
is required for maximal p53 accumulation in response to ionizing
radiation (IR), doxorubicin, or mitomycin C treatment, and that
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coexpression of c-Abl overcomesMDM2-mediated ubiquitination and
nuclear export of p53 (20). c-Abl phosphorylates MDM2 Tyr394 as
well as Tyr276 and Tyr405 (12, 13), and c-Abl phosphorylation of
MDM2 Tyr394 impairs the ability of MDM2 to inhibit p53 sta-
bilization and transactivation and p53-mediated apoptosis (12).
More recently, it was proposed that c-Abl phosphorylation of
MDM2 increases MDM2–MDMX binding and promotes MDM2-
directed MDMX ubiquitination, and that this ultimately destabilizes
the MDM2–MDMX complex, promoting p53 stabilization (21).
As we have shown that ATM phosphorylation of Mdm2
Ser394 profoundly impacts the p53 response to DNA damage in
mice, we sought to determine whether c-Abl phosphorylation of
Mdm2 Tyr393 similarly regulates p53 functions in vivo. To this end,
we generated a knockin mouse model in which Mdm2 Tyr393 is
substituted with phenylalanine (Mdm2Y393F), as well as a mouse in
which both the c-Abl target residue Mdm2 Tyr393 and the adjacent
ATM target residue Mdm2 Ser394 are mutated (Mdm2Y393F/S394A),
enabling the study of whether phosphorylation of these residues has
additive or redundant effects.
Results
Mdm2Y393F Mice Are Viable and Display Increased Spontaneous and
Oncogene-Induced Tumorigenesis. To investigate the role of Mdm2
Tyr393 phosphorylation under physiological conditions, we gen-
erated a mouse model in which this tyrosine residue is substituted
with a phenylalanine residue (Y393F). Site-directed mutagenesis
was performed to introduce an A-to-T missense mutation in the 393
codon, and a synonymous G-to-C mutation in the 397 codon of
Mdm2 exon 12 (Fig. 1A). A gene-replacement vector was con-
structed to replace the endogenous Mdm2 exon 12 sequences with
the mutated exon 12 (Fig. S1A). Gene targeting was performed in
PC3 (129SV) embryonic stem (ES) cells (22), and homologous re-
combination was confirmed in G418-resistant clones by Southern
blotting (Fig. S1 A–C). Blastocyst injection of targeted ES clones
produced several high-degree male chimeras that passed the Mdm2
Y393F allele through their germ line. Southern blotting further
confirmed proper targeting in F1 and F2 generation mice, along
with protamine-Cre–directed deletion of the floxed neomycin cas-
sette (Fig. S1 D and E). The presence of the additional synonymous
G-to-C mutation within the 397 codon of the targeted allele in-
troduced a novel BtsCI restriction digest site that allowed for
identification of the Mdm2Y393F allele by PCR-digest strategy (Fig.
1A and Fig. S1F). Mdm2 transcripts from spleens of Mdm2Y393F
mice were sequenced and confirmed as containing only the targeted
mutations (Fig. 1A). Heterozygous intercrosses yielded homozygous
Mdm2Y393F mice at Mendelian ratios, indicating that Mdm2Y393F is
not compromised in its function during development (Fig. S1G).
Additionally, no differences were observed in average litter size,
body weights at 6 wk of age, or male-to-female sex distribution.
We have previously shown that mice deficient for phosphorylation
of the neighboring residue (Mdm2 Ser394) by ATM are prone to
spontaneous tumorigenesis (11). Therefore, we sought to examine
whether c-Abl phosphorylation of Mdm2 Tyr393 impacted tu-
mor suppression. Cohorts of WT and Mdm2Y393F mice were
established and monitored for tumor formation. During the 24-mo
tumor assay, 8 of 21 (38%)Mdm2Y393Fmice developed spontaneous
tumors (Fig. 1B), whereas only 1 of 28 (4%) WT mice presented
with a tumor at 20 mo of age.Mdm2Y393F tumors arose between 14.5
and 24 mo of age, a similar latency as seen inMdm2S394A mice (11).
The majority of tumors arose in lymphatic tissues, and 5 of the 6
tumors (83%) were identified as B-cell lymphomas, with one of the
B-cell lymphomas also containing atypical T cells. Other tumor types
seen in the cohort included a myeloid sarcoma, a hepatocellular
carcinoma, and a papillary tumor of lacrimal origin (Fig. 1 C–E).
As Mdm2Y393F mice were more prone to develop spontaneous
tumors of lymphoid origin, we further examined the effects of
Mdm2-Y393 phosphorylation on tumor suppression using the
Eμ-Myc mouse model (23). Cohorts of Eμ-Myc and Eμ-Myc;
Mdm2Y393F mice were generated (C57BL/6 background) and
assayed for tumor formation. Eμ-Myc mice develop pre-B/B-cell
lymphomas within 3–6 mo of age, and we observed a median
time to tumorigenesis of 125.5 d in the Eμ-Myc model cohort
(Fig. 1F), a duration in close agreement with previous studies
(23, 24). However, Eμ-Myc;Mdm2Y393F mice displayed signifi-
cantly accelerated tumorigenesis, with a median time to tumor
formation of only 76.5 d. Thus, whereas dispensable for devel-
opment, c-Abl phosphorylation of Mdm2-Y393 significantly
impacts tumorigenesis by preventing the formation of both
spontaneous and oncogene-induced tumors.
c-Abl Phosphorylation of Mdm2 Tyr393 Does Not Influence DNA
Damage-Induced p53 Stabilization and Activation in Spleen and
Thymus. Having observed increased lymphomagenesis in Mdm2Y393F
mice, and as c-Abl is activated by a variety of DNA damaging agents
(14–16), we next examined whether c-Abl phosphorylation of
Mdm2 Tyr393 impacts DNA damage-induced p53 stabilization
and activation in lymphatic tissues of Mdm2Y393F mice. WT and
Fig. 1. Mdm2Y393F mice are viable and display increased spontaneous and
oncogene-induced tumorigenesis. (A) DNA sequence of WT and Mdm2Y393F
allele surrounding codon 393 (Top). An A-to-T mutation changed codon 393
from Tyr to Phe. A silent G-to-C mutation in codon 397 introduced a BtsCI re-
striction site. Sequencing results of the corresponding region from Mdm2Y393F
spleen cDNA are shown (Bottom). (B) Kaplan–Meier tumor-free survival curves
ofWT (n = 28) andMdm2Y393F (n = 21) mice. Curves were compared by log-rank
test: (P < 0.01). (C) Table displaying the latency, location, and tumor type for
spontaneous tumors arising in Mdm2Y393F mice. LN, lymph node; HCC, hepa-
tocellular carcinoma. (D) Representative H&E-stained tissue sections of a LN
exhibiting a B-cell lymphoma (Left) and myeloid sarcoma present in the liver
sinusoids (Right). (Scale bars, 100 μm.) (E) The B-cell lymphomas show expres-
sion of B220 (Left), and the myeloid neoplasms exhibit chloroacetate esterase
(Leder) staining (Right). (Scale bars, 100 μm.) (F) Kaplan–Meier tumor-free
survival curves of Eμ-Myc (n = 16) and Eμ-Myc;Mdm2Y393F (n = 16) mice.
Median survival times were as follows: Eμ-Myc (125.5 d), Eμ-Myc;
Mdm2Y393F (76.5 d). Curves were compared by log-rank test (P < 0.0001).








Mdm2Y393Fmice were exposed to 5 Gy IR and spleens were analyzed
for p53 and Mdm2 levels by immunoblotting (Fig. 2A). In both
genotypes, c-Abl cleavage was observed in response to IR, similar to
previous observations in cells undergoing stress-induced apoptosis
(25, 26). c-Abl phosphorylation at Tyr245 confirmed kinase activa-
tion. No qualitative differences were detected in basal or IR-induced
p53 protein levels. Similarly, no obvious differences were observed in
p53 activation as indicated by levels of p53-Ser18 phosphorylation. No
differences were observed in the levels of Mdm2 protein, which in-
creased at 2–4 h following IR, before decreasing as p53 activity di-
minished, similar to what has previously been reported in this tissue
(11, 27). The lack of a difference in p53 stabilization was confirmed
quantitatively in biological triplicates at 0, 2, and 4 h (Fig. S2A).
Similar results were observed in thymi from these same animals, with
no qualitative differences detected in the levels of total p53, phos-
phorylated p53 (S18), or Mdm2, save for slightly higher basal Mdm2
levels in Mdm2Y393F mice (Fig. S2B). Consistent with equal levels of
basal and IR-induced p53 protein stabilization and phosphorylation,
real-time quantitative PCR (RT-qPCR) performed on cDNA from
untreated and irradiated spleens of WT and Mdm2Y393F mice de-
tected no differences in the basal or DNA damage-induced expres-
sion levels of a selection of p53-target genes involved in growth arrest,
apoptosis, DNA repair, or metabolic regulation (Fig. 2B). Similar
results were observed in thymi (Fig. S2C).
Hematopoietic organs are highly radiosensitive, and p53 ac-
tivation in these tissues triggers widespread apoptosis following
IR (28). In keeping with the absence of observable differences in
p53 stabilization and activation in Mdm2Y393F spleens and thymi,
we detected no differences in splenic or thymic apoptosis in
untreated and irradiated Mdm2Y393F mice by TUNEL (Fig. 2C
and Fig. S2D). This observation was confirmed quantitatively by
flow cytometry of Annexin V-FITC–stained splenocytes and
thymocytes (Fig. S2 E and F). Thus, the IR-induced stabilization
and activation of p53 and the resultant apoptotic response is
unaltered in Mdm2Y393F spleens and thymi.
We also examined whether Mdm2 Tyr393 phosphorylation
affected p53-dependent growth arrest. MEFs fromWT,Mdm2Y393F,
and p53−/− mice were untreated or exposed to either 5 Gy IR or
150 nM doxorubicin for 18 h. Flow cytometric cell-cycle analysis
revealed no differences in growth arrest in Mdm2Y393F MEFs fol-
lowing either irradiation or treatment with doxorubicin (Fig. S2G).
Furthermore, WT and Mdm2Y393F MEFs exhibited similar growth
rates in standard cell proliferation assays (Fig. S2H).
Mdm2Y393F Mice Are Radioresistant and Display Enhanced Bone
Marrow Repopulating Abilities Following IR Exposure. The pro-
posed effects of c-Abl phosphorylation of Mdm2 on p53 are
similar to those of ATM phosphorylation of Mdm2, namely p53
stabilization and activation. Conversely, our findings that DNA
damage-induced p53 stabilization and activation in spleen and
thymus, and p53-dependent apoptosis and growth arrest in
Mdm2Y393F tissues and cells, are unaltered contrasts with what
we have reported with Mdm2S394A mice. Thus, c-Abl’s phos-
phorylation of Mdm2-Y393 may either have limited effect on the
p53-dependent DDR or may be adequately compensated for by
ATM phosphorylation of Mdm2 Ser394. However, when we
challenged cohorts of WT and Mdm2Y393F mice to a series of IR
doses spanning the threshold-lethal range, we observed a sig-
nificant resistance to whole-body IR-induced lethality inMdm2Y393F
mice (Fig. 3A). Following treatment with 8 Gy IR, 74% of
Mdm2Y393F mice survived to 4 wk compared with 22% survival of
WT mice. Similarly, 29% of Mdm2Y393F mice survived to 4 wk
after exposure to 9 Gy IR compared with 7% of WT mice. All
mice survived 7 Gy IR for both genotypes, whereas no mice of
either genotype survived past 2 wk following 10 Gy IR. The
majority of mice succumbed between 1 and 3 wk post-IR. Le-
thality in mice treated with this range of IR doses is routinely
attributed to p53-dependent bone marrow failure, referred to as
“hematopoietic syndrome” (29). As we have described a similar
resistance to whole-body IR in Mdm2S394A mice (11), we next
compared the effects of IR on bone marrow from WT,Mdm2Y393F,
Mdm2S394A, and p53−/− mice. Expression of p53-target genes Puma
and p21 are unaltered in Mdm2Y393F bone marrow, in agreement
with what was observed in irradiated spleen and thymus (Fig. S3A).
Conversely, expression levels of those same target genes are sig-
nificantly reduced in Mdm2S394A bone marrow, in keeping with the
previously described reduced IR-induced p53 responses in these
animals (11). However, similar initial reductions in bone marrow
cellularity were observed in both mutants, as well as in WT mice
and in p53−/− mice following treatment with 5 Gy IR (Fig. 3B).
Thus, the initial reduction in gross cellularity appears, to some ex-
tent, to be independent of p53. Flow cytometry analysis of untreated
bone marrow from WT, Mdm2Y393F, Mdm2S394A, and p53−/−
mice revealed no differences in the populations of lineage-defined,
mature hematopoietic cells, save for statistically fewer Cd11b+
cells in p53−/− mice (Fig. S3B). In agreement with the ob-
served reduction in bone marrow cellularity in all genotypes,
IR treatment induced a cumulative decline in populations of
mature cells in bone marrow from each genotype (Fig. S3C).
Fig. 2. c-Abl phosphorylation ofMdm2 Tyr393 does not
influence DNA damage-induced p53 stabilization and
activation in spleen and thymus. (A) WT andMdm2Y393F
mice were left untreated or exposed to 5 Gy IR and
spleens were harvested at 2-h intervals. Protein levels
were analyzed by Western blotting. TKO indicates
Mdm2−/−, MdmX−/−, p53−/− triple knockout control; Tg
indicates Mdm2Tg/+ Mdm2 overexpressing control.
(B) Mice were left untreated or exposed to 5 Gy IR
and spleens were harvested at 4 h. Fold expression of
p53-target genes was determined by RT-qPCR, rela-
tive to untreated WT samples using Rplp0 as internal
reference (n = 3–4, ± SEM). Significance was de-
termined by Student’s t test of ΔΔCt values.
(C) TUNEL staining of spleens of mice treated as in A
and harvested at 3 and 6 h.
15026 | www.pnas.org/cgi/doi/10.1073/pnas.1611798114 Carr et al.
Only p53−/− mice displayed significantly more B220+ cells. Again,
no differences were observed in the absence of treatment, in
the more primitive Lin−Sca1−cKit+ (L−S−K) progenitor pop-
ulations of WT, Mdm2Y393F, Mdm2S394A, or p53−/− mice (Fig.
S3D). However, whereas L−S−K cell numbers decreased 70–
80% in WT, Mdm2Y393F, and Mdm2S394A bone marrows, bone
marrow from p53−/− mice retained significantly more L−S−K
cells following IR. This finding suggests that increased survival
of hematopoietic progenitors underlies the resistance to IR-
induced bone marrow failure in mice with compromised p53.
Indeed, when Lin−Sca1+cKit+ (L−SK) hematopoietic stem and
progenitor cells (HSPCs) were quantified in these same ani-
mals, we observed no decrease following irradiation in p53−/−
mice (Fig. 3C). Whereas greater numbers of HSPCs were ob-
served in untreated p53−/− mice, no differences were observed
in HSPC number in untreated WT, Mdm2Y393F, andMdm2S394A
mice. However, there were significantly more HSPCs in
Mdm2S394A bone marrow following IR, and HSPC levels also
appeared slightly (although not statistically) elevated in irra-
diated Mdm2Y393F bone marrow. We examined whether the
resistance to acute whole-body IR-associated lethality observed in
Mdm2Y393F andMdm2S394A mice was due to an increased capacity
to repopulate irradiated marrow by performing H&E stains on
bone marrow from mice either untreated or 6 and 9 d following
8 Gy IR (Fig. 3D). At 6 d post-IR, whereas mice of all three
genotypes displayed evidence of a significant decrease in cellu-
larity, both p53−/−and Mdm2S394A bone marrow, and to a lesser
extent Mdm2Y393F bone marrow, contained multiple colonies of
hematopoietic cells that were not apparent in WT bone marrow,
as well as visibly more erythrocytes. By 9 d post-IR, coinciding with
the period of observed morbidity in threshold-lethally irradiated
animals, an even larger discrepancy in cellularity was observable
between WT and mutant bone marrows. Few hematopoietic col-
onies were visible in WT marrow, whereas colonies present in
p53−/−andMdm2S394A mice had expanded significantly and largely
replenished the medullary cavity. Whereas there was greater vis-
ible repopulation in Mdm2Y393F bone marrow compared with
WT, this repopulation appeared intermediate to that observed in
Mdm2S394A bone marrow, trending with the observed improved
HSPC survival following IR.
Mdm2 Tyr393 and Ser394 Phosphorylations Are Not Additive in Their
Impact on Tumor Suppression and Radioresistance. To determine
whether the shared effects of Mdm2 Tyr393 and Ser394 phos-
phorylation were redundant or additive, we generated a knockin
mouse in which both the Tyr393 residue is substituted with a
phenylalanine residue (Y393F) and the Ser394 residue is substituted
with an alanine (S394A) (Fig. 4A). Gene targeting was carried out
following a similar strategy as used for Mdm2Y393F mice (Fig. S4
A–E). The targeting construct coded for an A-to-T missense muta-
tion in the 393 codon, a T-to-G missense mutation in the 394 codon,
and a synonymous T-to-G mutation in the 398 codon ofMdm2 exon
12, which also facilitated PCR-digest genotyping of cells and mice.
As observed for Mdm2S394A mice (11), Mdm2Y393F/S394A mice were
recovered from heterozygous intercrosses at Mendelian ratios (Fig.
S4F). A cohort of biallelic Mdm2Y393F/S394A mice was monitored for
spontaneous tumor presentation, and by 24 mo, 14 of 21 (67%)
of these mice presented with tumors (Fig. 4B). This result mir-
rors the 65% of Mdm2S394A mice that developed spontaneous
tumors in our previous study (11), as does the observed latency
of 18–24 mo for the majority of tumors. Consequently, the tumor
suppressive effects of Mdm2 Tyr393 phosphorylation by c-Abl
and Mdm2 Ser394 phosphorylation by ATM do not appear to
be additive or synergistic. The predominant tumor type in
Mdm2Y393F/S394A mice was B-cell lymphoma (6/15, 40%), along
with myeloid sarcomas (5/15, 33%), hepatocellular carcinomas
(3/15, 20%), and one tumor that appeared to be a liver metas-
tasis of neuroendocrine cell origin (Fig. 4 C–E).
Irradiated thymi from Mdm2Y393F/S394A mice were examined
by immunoblotting, as well as by qPCR of p53-target gene
transcripts, and showed a similar reduction of p53 stabilization
and activity as observed in Mdm2S394A mice (Fig. S5 A and B).
This finding is in keeping with the absence of observable
defects in the p53 response to DNA damage in Mdm2Y393F
mice described in Fig. 2 and Fig. S2. Accordingly, whereas
reduced in comparison with WT, no additional deficits in
apoptosis were observed by TUNEL staining or Annexin V
Fig. 3. Mdm2Y393F mice are radioresistant and display improved bone marrow repopulation following IR exposure. (A) Kaplan–Meier survival curves of
WT (n = 7–18) and Mdm2Y393F (n = 6–19) mice exposed to 7, 8, 9, and 10 Gy whole-body IR. WT and Mdm2Y393F curves were compared by log-rank test:
7 Gy (n.s.), 8 Gy (P = 0.003), 9 Gy (P = 0.030), and 10 Gy (n.s.). (B) Quantification of numbers of nucleated cells in bone marrow from both hindlimbs of
WT, Mdm2Y393F,Mdm2S394A, and p53−/− mice either untreated or 8 h after exposure to 5 Gy IR. (n = 3–6, ± SEM). *P < 0.05, **P < 0.01 (Student’s t tests).
(C ) Quantification of L–SK HSPCs in bone marrow of WT, Mdm2Y393F, Mdm2S394A, and p53−/− mice treated as described in B. *P < 0.05, **P < 0.01
(Student’s t tests). (D) H&E stained bone marrow from WT, Mdm2Y393F, Mdm2S394A, and p53−/− mice exposed to 8 Gy IR. Yellow arrows indicate nascent
hematopoietic cell colonies. (Scale bars, 100 μm.)








staining followed by flow cytometry of Mdm2Y393F/S394A
thymi relative to those seen in Mdm2S394A thymi (Fig. S5 C
and D).
Finally, we examined whether the radioresistant phenotypes
observed in Mdm2Y393F and Mdm2S394A mice were exacerbated
in Mdm2Y393F/S394A mice. Mdm2S394A and Mdm2Y393F/S394A mice
were exposed to 9 Gy whole-body IR (as used for Mdm2Y393F
mice) and monitored for signs of morbidity (Fig. 4F). No significant
difference in survival was observed between Mdm2S394A and
Mdm2Y393F/S394A mice at this dose, with 82% of Mdm2S394A mice
and 69% of Mdm2Y393F/S394A mice surviving at 4 wk, respectively.
However, both genotypes are significantly more radioresistant than
Mdm2Y393F mice, which are themselves significantly more radio-
resistant than WT mice at this dose. Thus, radioresistance resulting
from the loss of either Mdm2 Tyr393 phosphorylation by c-Abl or
Mdm2 Ser394 phosphorylation by ATM is not increased by muta-
tion of both phospho-target residues. Accordingly, IR-induced ex-
pression levels of p53-target genes in irradiated bone marrow of
Mdm2S394A and Mdm2Y393F/S394A mice are similarly reduced (Fig.
S6A). The equivalent deficiency in the p53 response in Mdm2S394A
and Mdm2Y393F/S394A bone marrow follows with comparably in-
creased numbers of L−SK HSPCs surviving in Mdm2Y393F/S394A
bone marrow following IR (Fig. 4G). Furthermore, bone marrow
cells from Mdm2Y393F/S394A or Mdm2S394A mice exhibit similar he-
matopoietic repopulating abilities in vivo (Fig. S6B). As was
observed with Mdm2Y393F and Mdm2S394A mice, no differences
were seen in the number of lineage-defined or L−S−K hemato-
poietic cells (Fig. S6 C and D).
Discussion
These findings provide further evidence of the significance of
phosphorylation of Mdm2 by DNA damage-activated kinases
in regulating p53-dependent organismal responses. Mdm2Y393F
mice are viable and display no developmental defects, yet they
are significantly more prone to developing spontaneous tumors
over their lifespan (Fig. 1B). The spontaneous tumors arising in
Mdm2Y393F mice are primarily hematopoietic in nature and led
us to examine whether Mdm2 Tyr393 phosphorylation im-
pacted oncogene-induced tumorigenesis using the Eμ-Myc al-
lele. Indeed, Eμ-Myc;Mdm2Y393F mice developed tumors at a
significantly accelerated rate (Fig. 1F).
The increased spontaneous tumorigenesis rates and accelerated
B-cell lymphomagenesis are a likely result of reduced p53 activity
in Mdm2Y393F and Eμ-Myc;Mdm2Y393F mice, as p53-dependent
apoptosis and senescence have been shown to inhibit spontane-
ous tumorigenesis and B-cell tumors induced by aberrant Myc
activity (24, 30–32). However, we observed no defects in p53-
dependent apoptosis in spleens or thymi of Mdm2Y393F mice
following IR, or p53-dependent growth arrest in MEFs treated
with IR or doxorubicin (Fig. 2 and Fig. S2). It is conceivable that
Mdm2 phosphorylation by c-Abl can regulate p53 tumor sup-
pressing effects other than apoptosis or growth arrest, and/or that
subtle differences in these p53 functions inMdm2Y393Fmice are not
detectable by examining the effects of acute damage on p53 tumor
suppression. Furthermore, it is possible that additional c-Abl target
residues on Mdm2 can compensate for the loss of Mdm2 Tyr393
phosphorylation (12, 13).
Seemingly incongruously, Mdm2Y393F mice are resistant to
threshold-lethal doses of radiation (Fig. 3A). This radioresistance
parallels our previous observations with Mdm2S394A mice, which
display profound defects in p53-dependent apoptosis and tissues.
HSPC or bone marrow cells from both mutants display improved
repopulating functions following IR exposure, albeit to a greater
extent in Mdm2S394A mice (Fig. 3D). In keeping with this dif-
ference, HSPCs in Mdm2S394A bone marrow display a significant
survival advantage following IR, whereas Mdm2Y393F HSPCs
display only a marginal increase in survival after DNA damage.
However, the slight increase in the survival of Mdm2Y393F HSPCs
manifests increased radioresistance in Mdm2Y393F mice relative to
WT mice.
Fig. 4. Mdm2 Tyr393 and Ser394 phosphorylations are not additive in their impact on tumor suppression or radioresistance. (A) DNA sequence of WT and
Mdm2Y393F/S394A allele surrounding codons 393 and 394 (Top). An A-to-T mutation changed codon 393 from Tyr to Phe. A T-to-C mutation changed codon 394
from Ser to Ala. A silent T-to-G mutation in codon 398 introduced a AatII restriction site. Sequencing results of the corresponding region fromMdm2Y393F/S394A
spleen cDNA are shown (Bottom). (B) Kaplan–Meier tumor-free survival curve ofMdm2Y393F/S394A mice (n = 21). Included are tumor-free survival curves of WT
and Mdm2Y393F mice described in Fig. 1B and Mdm2S394A mice described previously (11). Curves were compared by log-rank test: Mdm2Y393F/S394A to WT (P <
0.0001) and Mdm2Y393F/S394A to Mdm2Y393F (P = 0.080). (C) Table displaying the latency, location, and tumor type for spontaneous tumors arising in
Mdm2Y393F/S394A mice. LN, lymph node; HCC, hepatocellular carcinoma; Neu, neuroendocrine. (D) Representative H&E-stained tissue sections of a B-cell
lymphoma (Left), myeloid sarcoma (Middle), and hepatoma (Right) that developed in Mdm2Y393F/S394A mice. (Scale bars, 100 μm.) (E) B-cell lymphoma shows
expression of B220 (Left), and a myeloid neoplasm exhibits chloroacetate esterase (Leder) activity (Right). (Scale bars, 100 μm.) (F) Kaplan–Meier survival
curves of WT (n = 15),Mdm2Y393F (n = 17), Mdm2S394A (n = 11), and Mdm2Y393F/S394A (n = 13) mice exposed to 9 Gy whole-body IR. Curves were compared by
log-rank test: WT to Mdm2Y393F (P = 0.030), WT to Mdm2S394A (P < 0.0001), WT to Mdm2Y393F/S394A (P < 0.0001), Mdm2Y393F to Mdm2S394A (P = 0.010),
Mdm2Y393F to Mdm2Y393F/S394A (P = 0.020), and Mdm2S394A to Mdm2Y393F/S394A (n.s.). (G) Quantification of L–SK HSPCs in bone marrow of WT, Mdm2Y393F,
Mdm2S394A, and Mdm2Y393F/S394A mice untreated or 8 h following 5 Gy IR (n = 3–6, ± SEM). *P < 0.05, **P < 0.01 (Student’s t tests).
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The generation of Mdm2Y393F/S394A mice allowed us to ex-
amine whether the common effects of Mdm2 Tyr393 phos-
phorylation by c-Abl and Mdm2 Ser394 phosphorylation by
ATM are additive or redundant. We observed no additive or
synergistic effects of the loss of both phosphorylation events on
the incidence of spontaneous tumorigenesis, with Mdm2Y393F/S394A
mice developing spontaneous tumors at a frequency and latency
that nearly overlaps what we have reported withMdm2S394Amice
(Fig. 4B). Similarly, we observed no additive effects on radio-
resistance, with Mdm2Y393F/S394A and Mdm2S394A mice displaying
comparable survival, HSPC numbers, and bone marrow reconstitution
following whole-body IR (Fig. 4 F and G and Fig. S6). Hence,
there is an apparent redundancy of the shared phenotypes be-
tween Mdm2Y393F and Mdm2S394A mice, with tumorigenesis and
radioresistance in Mdm2Y393F/S394A mice never exceeding that
observed in Mdm2S394A mice. This may reflect the proposed in-
terdependence of c-Abl and ATM for their respective activities
(16, 33, 34). However, ATM phosphorylation of Mdm2 Ser394
clearly has a predominant effect on Mdm2-p53 signaling and p53
functions, relative to the effects induced by c-Abl phosphoryla-
tion of Mdm2 Tyr393.
Methods
Mice and Animal Studies. All animals described in this study were on a C57BL/6
background. Mice and cells were irradiated with a cesium-137 source
(Gammacell 40). The generation of Mdm2S394A mice has been previously
described (11). Eμ-Myc mice were a gift from Christine Eischen, Vanderbilt
University, Nashville. TN. A detailed description of the generation and
genotyping of Mdm2Y393F and Mdm2Y393F/S394A mice is provided in SI
Methods. All animals used in this study were maintained and assayed in
accordance with federal guidelines and those established by the Institutional
Animal Care and Use Committee at the University of Massachusetts Medical
School (UMMS).
Immunoblotting. Tissues and cells were lysed in Nonidet P-40 lysis buffer
supplemented with protease and phosphatase inhibitors. A detailed descrip-
tion of the methods used, including antibodies and clones, is provided in
SI Methods.
Gene Expression Analysis and Sequencing. Total RNA was isolated from tissues
by RNeasy Mini Kit (Qiagen) and cDNA synthesized by the SuperScript III First
Strand Synthesis System (Invitrogen). qPCR was performed using SYBR Select
Master Mix (Applied Biosystems) in conjunction with a 7300 Real-Time PCR
System (Applied Biosystems). A detailed description of the methods used for
qPCR and sequencing is provided in SI Methods.
Histopathology. Tissue samples were fixed in 10% (vol/vol) formalin for 24 h.
The UMMS Morphology Core Laboratory performed embedding, sectioning,
and staining. TUNEL staining was performed using the In Situ Cell Death
Detection Kit, POD (Roche) according to manufacturer’s instructions. Im-
munohistochemistry was performed with antibodies specific for B220
(550286; BD Pharmingen) and CD3 (A0452; Dako). Naphthol chloroacetate
esterase staining was performed to detect cells with myeloid differentiation.
Stained tissue was analyzed using an Olympus CX41 microscope fitted with a
PixeLINK camera and software.
Bone Marrow Analysis. Total bone marrow from both hind limbs was har-
vested, RBCs were lysed, and single-cell suspensions were stained with cell-
surface antibodies for Gr-1, CD11B, CD3, and B220. For LSK analysis, bone
marrow cells were stained with a biotin lineage mixture and antibodies for
Sca-1, c-Kit, CD34, and Flk2. All samples were run on a BD LSRII flow cytometer
(BD Biosciences) and analyzed using FlowJo software (Tree Star). A complete
list of antibodies including clone numbers is given in Table S1.
Statistical Analysis. Statistical analyses were performed using GraphPad Prism
software, version 6.0d. Kaplan–Meier survival curves were analyzed by log-
rank test. A P value of <0.05 was considered statistically significant for
Student t tests.
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